Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Pharmaceuticals, News And Latest Headlines - I24NEWS
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
TEVA Stock Alert: What to Know About Teva Pharmaceuticals' New CEO | InvestorPlace
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva plans massive layoffs; Overland Park office's future unclear - Kansas City Business Journal
Teva: Generic drug giant stumbles into NJ with $40M tax break from you
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
Teva Pharmaceuticals (@TevaUSA) / Twitter
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
Teva Pharmaceuticals found liable for role in New York opioid epidemic - UPI.com
Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune
Opioid Manufacturer Teva Pharmaceuticals Reaches $4B Global Settlement | Law.com